Beijing Marr Bio-Pharmaceutical Co., Ltd. is located in Beijing Huairou Yanqi Industrial Development Zone and was found in 2005. After 10 years of unremitting efforts, Marr Bio has witnessed the progress of non-invasive HIV testing in China, helping China's HIV prevention.
The company is committed to the production, research and development of in vitro diagnostic reagents. The main product "aware" is a non-invasive HIV test product that has passed CFDA (China Food and Drug Administration) certification as early as 2008. As a pioneer in the non-invasive HIV detection industry, Marr Bio holds a number of patents including Chinese invention patents, utility models and design patents for saliva detection HIV technology.
The company covers the entire industrial chain of R & D, production and sales, and has a clear business model, which is very different from the traditional reagent industry. Driven by the positioning of "POCT + FMCG + Internet" products, the sales volume of Marr Bio has increased year by year, with an annual growth rate of nearly 100%, and the market share of Aware is nearly 60%.
Marr Bio always adheres to the concept of "quality is life, precision is responsibility", insists on selecting core raw materials from the world's best suppliers, and the production workshop has passed the double certification of ISO 9001 and ISO 13485. The annual production capacity of the factory is 100 million. Domestic and foreign organizations and institutions such as the United States GAP (affiliated to the US CDC China Office), China-Gates HIV Program, and the National CDC (National Center for Disease Control and Prevention) have choose the Aware.